SMTL ID : 8e81.1

Structure of LRRK2-CHK1 10-pt. mutant complex with heteroaryl-1H-indazole LRRK2 inhibitor 25

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.62 Å

Oligo State

monomer

Ligands

1 x UU6: (1S)-1-[(1P)-1-{6-[(3R)-3-(2-hydroxypropan-2-yl)pyrrolidin-1-yl]pyrimidin-4-yl}-1H-indazol-6-yl]spiro[2.2]pentane-1-carbonitrile(Non-covalent)

UU6.1: 16 residues within 4Å: Chain A: L.15, G.16, V.23, L.25, A.36, M.84, E.85, L.86, A.87, S.88, G.90, H.134, N.135, L.137, A.147, D.148 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:L.15, A:V.23, A:V.23, A:L.25, A:A.36, A:L.86, A:L.137, A:A.147 Hydrogen bonds: A:A.87, A:S.88, A:D.148 Water bridges: A:Y.149

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Candito, D.A. et al., Discovery and Optimization of Potent, Selective, and Brain-Penetrant 1-Heteroaryl-1 H -Indazole LRRK2 Kinase Inhibitors for the Treatment of Parkinson's Disease. J.Med.Chem. (2022)

Release Date

2023-02-22

Peptides

Serine/threonine-protein kinase Chk1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Serine/threonine-protein kinase Chk1

Related Entries With Identical Sequence